Article(id=1329869572552896995, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869572141855203, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.02.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1666886400000, receivedDateStr=2022-10-28, revisedDate=1673452800000, revisedDateStr=2023-01-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995213878, onlineDateStr=2026-11-18, pubDate=1675958400000, pubDateStr=2023-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995213878, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995213878, creator=13701087609, updateTime=1794995213878, updator=13701087609, issue=Issue{id=1329869572141855203, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='2', pageStart='105', pageEnd='196', issueExtLink='null', onlineDate='null', pubDate='1675958400000', pubDateStr='2023-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995213780, creator='13701087609', updateTime=1794995798529, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329872025146995085, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869572141855203, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329872025146995086, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869572141855203, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=122, endPage=127, ext={EN=ArticleExt(id=1329869572787778020, articleId=1329869572552896995, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progresson the role of glucose-dependent insulinotropic ploypeptide/glucagon-like peptide-1 dual receptor agonists in blood glucose control, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Glucose-dependent insulinotropic ploypeptide (GIP) and glucagon-like peptide (GLP)-1 are two main types of incretin. Both of them can increase glucose-dependent insulin secretion and play a hypoglycemic role. In recent years, the efficacy of GLP-1 receptor agonists for diabetes mellitus type 2 (T2DM) has been widely recognized, but the effect of GIP on T2DM is still unclear. When GIP is combined with GLP-1 in a single molecule double agonist, it can show a significant synergistic effect. This article summarized the role of GIP/GLP-1 dual receptor agonists in glycemic control in patients with T2DM and the new findings from preclinical and clinical studies to provide reference for clinical practice.

, authors=Feijuan KONG, Jingzhu WU, Xiaoying DING*, authorsList=Feijuan KONG, Jingzhu WU, Xiaoying DING, authorCompany=null, correspAuthors=Xiaoying DING, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329869573060407781, articleId=1329869572552896995, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1双受体激动剂在血糖控制中的作用研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

葡萄糖依赖性促胰岛素多肽(glucose-dependent insulinotropic ploypeptide,GIP)及胰高血糖素样肽(glucagon-like peptide,GLP)-1是两种主要的肠促胰岛素,二者均能增加葡萄糖依赖的胰岛素分泌,发挥降糖作用。近年来,GLP-1受体激动剂对2型糖尿病(diabetes mellitus type 2,T2DM)的疗效得到广泛认可,但关于GIP对T2DM的疗效仍未完全明确。当GIP与GLP-1在单分子双重激动剂中结合时,可表现出显著协同作用。现主要概述GIP/GLP-1双受体激动剂在T2DM患者血糖控制中的作用,及从临床前研究和临床研究中获得的新发现,旨在为临床提供参考。

, authors=孔飞娟, 吴景竹, 丁晓颖*, authorsList=孔飞娟, 吴景竹, 丁晓颖, authorCompany=null, correspAuthors=丁晓颖, authorNote=

孔飞娟,主治医师,研究方向:内分泌代谢疾病。

吴景竹,主治医师,研究方向:内分泌代谢疾病。

, correspAuthorsNote=
丁晓颖,主任医师,内分泌系统疾病的诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=OnWeY9cinnPOI1s07amw0Q==, magXml=m6ffEs9UpImXEnLuZCbpUQ==, pdfUrl=null, pdf=oogeuIRpqEhq28B7flBvcw==, pdfFileSize=2080680, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Xwp6MCkj3M0klXkhfUEt3A==, mapNumber=null, fund=null)}, authors=[Author(id=1329869573345620458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869573421117932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573345620458, language=EN, stringName=Feijuan KONG, firstName=Feijuan, middleName=null, lastName=KONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869573517586925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573345620458, language=CN, stringName=孔飞娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属第一人民医院内分泌代谢科,上海 200080, bio={"content":"

孔飞娟,主治医师,研究方向:内分泌代谢疾病。

"}, bioImg=null, bioContent=

孔飞娟,主治医师,研究方向:内分泌代谢疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])]), Author(id=1329869573630833135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869573756662257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573630833135, language=EN, stringName=Jingzhu WU, firstName=Jingzhu, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869573874102770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573630833135, language=CN, stringName=吴景竹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属第一人民医院内分泌代谢科,上海 200080, bio={"content":"

吴景竹,主治医师,研究方向:内分泌代谢疾病。

"}, bioImg=null, bioContent=

吴景竹,主治医师,研究方向:内分泌代谢疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])]), Author(id=1329869573966377460, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869574046069238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573966377460, language=EN, stringName=Xiaoying DING, firstName=Xiaoying, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869574146732535, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573966377460, language=CN, stringName=丁晓颖, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学附属第一人民医院内分泌代谢科,上海 200080, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])])], keywords=[Keyword(id=1329869574243201528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=EN, orderNo=1, keyword=glucose-dependent insulinotropic ploypeptide), Keyword(id=1329869574352253433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=EN, orderNo=2, keyword=glucagon-like peptide-1), Keyword(id=1329869574444528122, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=EN, orderNo=3, keyword=blood glucose control), Keyword(id=1329869574549385723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=EN, orderNo=4, keyword=hyperglycemia), Keyword(id=1329869574629077500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=CN, orderNo=1, keyword=葡萄糖依赖性促胰岛素多肽), Keyword(id=1329869574700380669, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=CN, orderNo=2, keyword=胰高血糖素样肽-1), Keyword(id=1329869574780072446, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=CN, orderNo=3, keyword=血糖控制), Keyword(id=1329869574842987007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, language=CN, orderNo=4, keyword=高血糖)], refs=[Reference(id=1329869575212085762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Bayliss WM, Starling EH. The mechanism of pancreatic secretion[J]. J Physiol, 1902, 28(5): 325-353., articleTitle=null, refAbstract=null), Reference(id=1329869575279194627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Moore B. On the treatment of diabetus mellitus by acid extract of duodenal mucous membrane[J]. Biochem J, 1906, 1(1): 28-38., articleTitle=null, refAbstract=null), Reference(id=1329869575392440836, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Mcintyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance[J]. Lancet, 1964, 2(7349): 20-21., articleTitle=null, refAbstract=null), Reference(id=1329869575455355397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Unger RH, Eisentraut AM. Entero-insular axis[J]. Arch Intern Med, 1969, 123(3): 261-266., articleTitle=null, refAbstract=null), Reference(id=1329869575535047174, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Eissele R, Göke R, Willemer S, et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man[J]. Eur J Clin Invest, 1992, 22(4): 283-291., articleTitle=null, refAbstract=null), Reference(id=1329869575648293383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Takeda J, Seino Y, Tanaka K, et al. Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor[J]. Proc Natl Acad Sci USA, 1987, 84(20): 7005-7008., articleTitle=null, refAbstract=null), Reference(id=1329869575761539592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Diakogiannaki E, Gribble FM, Reimann F. Nutrient detection by incretin hormone secreting cells[J]. Physiol Behav, 2012, 106(3): 387-393., articleTitle=null, refAbstract=null), Reference(id=1329869575874785801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Caruso I, Cignarelli A, Giorgino F. Heterogeneity and similarities in GLP-1 receptor agonist cardiovascular outcomes trials[J]. Trends Endocrinol Metab, 2019, 30(9): 578-589., articleTitle=null, refAbstract=null), Reference(id=1329869575962866186, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma X, Liu Z, Ilyas I, et al. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential[J]. Int J Biol Sci, 2021, 17(8): 2050-2068., articleTitle=null, refAbstract=null), Reference(id=1329869576050946571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Højberg PV, Vilsbøll T, Rabøl R, et al. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes[J]. Diabetologia, 2009, 52(2): 199-207., articleTitle=null, refAbstract=null), Reference(id=1329869576130638348, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Frias JP, Bastyr EJ 3rd, Vignati L, et al. The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes[J]. Cell Metab, 2017, 26(2): 343-352., articleTitle=null, refAbstract=null), Reference(id=1329869576210330125, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Frias JP, Nauck MA, Van J, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial[J]. Lancet, 2018, 392(10160): 2180-2193., articleTitle=null, refAbstract=null), Reference(id=1329869576344547854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Usdin TB, Mezey E, Button DC, et al. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain[J]. Endocrinology, 1993, 133(6): 2861-2870., articleTitle=null, refAbstract=null), Reference(id=1329869576424239631, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Gromada J, Bokvist K, Ding WG, et al. Glucagon-like peptide 1(7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling[J]. Diabetes, 1998, 47(1): 57-65., articleTitle=null, refAbstract=null), Reference(id=1329869576495542800, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Lewis JT, Dayanandan B, Habener JF, et al. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist[J]. Endocrinology, 2000, 141(10): 3710-3716., articleTitle=null, refAbstract=null), Reference(id=1329869576575234577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Irwin N, Gault V, Flatt PR. Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?[J]. Expert Opin Investig Drugs, 2010, 19(9): 1039-1048., articleTitle=null, refAbstract=null), Reference(id=1329869576646537746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Villar HV, Fender HR, Rayford PL, et al. Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP)[J]. Ann Surg, 1976, 184(1): 97-102., articleTitle=null, refAbstract=null), Reference(id=1329869576717840915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP[J]. Gastroenterology, 2007, 132(6): 2131-2157., articleTitle=null, refAbstract=null), Reference(id=1329869576801726996, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Elahi D, McAloon-Dyke M, Fukagawa NK, et al. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1(7-37) in normal and diabetic subjects[J]. Regul Pept, 1994, 51(1): 63-74., articleTitle=null, refAbstract=null), Reference(id=1329869576944333333, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Finan B, Ma T, Ottaway N, et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans[J]. Sci Transl Med, 2013, 5(209): 209ra151., articleTitle=null, refAbstract=null), Reference(id=1329869577024025110, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Gallwitz B, Witt M, Fölsch UR, et al. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide on RINm5F insulinoma cells[J]. J Mol Endocrinol, 1993, 10(3): 259-268., articleTitle=null, refAbstract=null), Reference(id=1329869577086939671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Delmeire D, Flamez D, Moens K, et al. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent β cell responsiveness[J]. Biochem Pharmacol, 2004, 68(1): 33-39., articleTitle=null, refAbstract=null), Reference(id=1329869577166631448, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Lupi R, Del GS, D'Aleo V, et al. The direct effects of GLP-1 and GIP, alone or in combination, on human pancreatic islets[J]. Regul Pept, 2010, 165(2-3): 129-132., articleTitle=null, refAbstract=null), Reference(id=1329869577242128921, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Gault VA, Kerr BD, Harriott P, et al. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with type 2 diabetes and obesity[J]. Clin Sci (Lond), 2011, 121(3): 107-117., articleTitle=null, refAbstract=null), Reference(id=1329869577346986522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Pathak NM, Pathak V, Gault VA, et al. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential[J]. Biochem Pharmacol, 2018, 155: 264-274., articleTitle=null, refAbstract=null), Reference(id=1329869577447649819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Irwin N, Hunter K, Frizzell N, et al. Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice[J]. Regul Pept, 2009, 153(1-3): 70-76., articleTitle=null, refAbstract=null), Reference(id=1329869577594450460, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Killion EA, Wang J, Yie J, et al. Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models[J]. Sci Transl Med, 2018, 10(472): eaat3392., articleTitle=null, refAbstract=null), Reference(id=1329869577716085277, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Mentis N, Vardarli I, Köthe LD, et al. GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes[J]. Diabetes, 2011, 60(4): 1270-1276., articleTitle=null, refAbstract=null), Reference(id=1329869577795777054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Krarup T, Saurbrey N, Moody AJ, et al. Effect of porcine gastric inhibitory polypeptide on β-cell function in type Ⅰand type Ⅱ diabetes mellitus[J]. Metabolism, 1987, 36(7): 677-682., articleTitle=null, refAbstract=null), Reference(id=1329869577879663135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Schmitt C, Portron A, Jadidi S, et al. Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus[J]. Diabetes Obes Metab, 2017, 19(10): 1436-1445., articleTitle=null, refAbstract=null), Reference(id=1329869577950966304, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Portron A, Jadidi S, Sarkar N, et al. Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects[J]. Diabetes Obes Metab, 2017, 19(10): 1446-1453., articleTitle=null, refAbstract=null), Reference(id=1329869578026463777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept[J]. Mol Metab, 2018, 18: 3-14., articleTitle=null, refAbstract=null), Reference(id=1329869578114544162, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Rosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial[J]. Lancet, 2021, 398(10295): 143-155., articleTitle=null, refAbstract=null), Reference(id=1329869578177458723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes[J]. N Engl J Med, 2021, 385(6): 503-515., articleTitle=null, refAbstract=null), Reference(id=1329869578252956196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Ludvik B, Giorgino F, Jódar E, et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial[J]. Lancet, 2021, 398(10300): 583-598., articleTitle=null, refAbstract=null), Reference(id=1329869578315870757, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Del PS, Kahn SE, Pavo I, et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial[J]. Lancet, 2021, 398(10313): 1811-1824., articleTitle=null, refAbstract=null), Reference(id=1329869578387173926, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Provenzano M, Pelle MC, Zaffina I, et al. Sodium-glucose co-transporter-2 inhibitors and nephroprotection in diabetic patients: more than a challenge[J]. Front Med (Lausanne), 2021, 8: 654557., articleTitle=null, refAbstract=null), Reference(id=1329869578450088487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Coppolino G, Leporini C, Rivoli L, et al. Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials[J]. Pharmacol Res, 2018, 129: 274-294., articleTitle=null, refAbstract=null), Reference(id=1329869578517197352, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Li VM, Fuiano G, Francesco M, et al. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency[J]. Nephron Clin Pract, 2007, 105(2): c62-c67., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329869575010759168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, awardId=21ZR1451300, language=CN, fundingSource=上海市自然科学基金面上项目(21ZR1451300), fundOrder=null, country=null), Fund(id=1329869575094645249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, awardId=null, language=CN, fundingSource=上海市“医苑新星”青年医学人才培养资助计划专科项目, fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.02.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.02.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.02.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.02.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1675958400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1双受体激动剂在血糖控制中的作用研究进展
孔飞娟 , 吴景竹 , 丁晓颖 *
世界临床药物 | 医药专论 2023,44(2): 122-127
收起
收藏切换
世界临床药物 |医药专论 2023 , 44 (2) : 122 -127
葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1双受体激动剂在血糖控制中的作用研究进展
全屏
[Author(id=1329869573345620458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869573421117932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573345620458, language=EN, stringName=Feijuan KONG, firstName=Feijuan, middleName=null, lastName=KONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869573517586925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573345620458, language=CN, stringName=孔飞娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属第一人民医院内分泌代谢科,上海 200080, bio={"content":"

孔飞娟,主治医师,研究方向:内分泌代谢疾病。

"}, bioImg=null, bioContent=

孔飞娟,主治医师,研究方向:内分泌代谢疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])]), Author(id=1329869573630833135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869573756662257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573630833135, language=EN, stringName=Jingzhu WU, firstName=Jingzhu, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869573874102770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573630833135, language=CN, stringName=吴景竹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属第一人民医院内分泌代谢科,上海 200080, bio={"content":"

吴景竹,主治医师,研究方向:内分泌代谢疾病。

"}, bioImg=null, bioContent=

吴景竹,主治医师,研究方向:内分泌代谢疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])]), Author(id=1329869573966377460, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869574046069238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573966377460, language=EN, stringName=Xiaoying DING, firstName=Xiaoying, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869574146732535, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, authorId=1329869573966377460, language=CN, stringName=丁晓颖, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学附属第一人民医院内分泌代谢科,上海 200080, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869573257540070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, xref=null, ext=[AuthorCompanyExt(id=1329869573270122983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China), AuthorCompanyExt(id=1329869573278511592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869572552896995, companyId=1329869573257540070, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属第一人民医院内分泌代谢科,上海 200080)])])]
孔飞娟, 吴景竹, 丁晓颖*
作者信息
  • 上海交通大学附属第一人民医院内分泌代谢科,上海 200080
通讯作者:
丁晓颖,主任医师,内分泌系统疾病的诊治。
作者简介:

孔飞娟,主治医师,研究方向:内分泌代谢疾病。

吴景竹,主治医师,研究方向:内分泌代谢疾病。

Research progresson the role of glucose-dependent insulinotropic ploypeptide/glucagon-like peptide-1 dual receptor agonists in blood glucose control
Feijuan KONG, Jingzhu WU, Xiaoying DING*
Affiliations
  • Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200080, China
出版时间: 2023-02-10 doi: 10.13683/j.wph.2023.02.004
文章导航
收藏切换

葡萄糖依赖性促胰岛素多肽(glucose-dependent insulinotropic ploypeptide,GIP)及胰高血糖素样肽(glucagon-like peptide,GLP)-1是两种主要的肠促胰岛素,二者均能增加葡萄糖依赖的胰岛素分泌,发挥降糖作用。近年来,GLP-1受体激动剂对2型糖尿病(diabetes mellitus type 2,T2DM)的疗效得到广泛认可,但关于GIP对T2DM的疗效仍未完全明确。当GIP与GLP-1在单分子双重激动剂中结合时,可表现出显著协同作用。现主要概述GIP/GLP-1双受体激动剂在T2DM患者血糖控制中的作用,及从临床前研究和临床研究中获得的新发现,旨在为临床提供参考。

葡萄糖依赖性促胰岛素多肽  /  胰高血糖素样肽-1  /  血糖控制  /  高血糖

Glucose-dependent insulinotropic ploypeptide (GIP) and glucagon-like peptide (GLP)-1 are two main types of incretin. Both of them can increase glucose-dependent insulin secretion and play a hypoglycemic role. In recent years, the efficacy of GLP-1 receptor agonists for diabetes mellitus type 2 (T2DM) has been widely recognized, but the effect of GIP on T2DM is still unclear. When GIP is combined with GLP-1 in a single molecule double agonist, it can show a significant synergistic effect. This article summarized the role of GIP/GLP-1 dual receptor agonists in glycemic control in patients with T2DM and the new findings from preclinical and clinical studies to provide reference for clinical practice.

glucose-dependent insulinotropic ploypeptide  /  glucagon-like peptide-1  /  blood glucose control  /  hyperglycemia
孔飞娟, 吴景竹, 丁晓颖. 葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1双受体激动剂在血糖控制中的作用研究进展. 世界临床药物, 2023 , 44 (2) : 122 -127 . DOI: 10.13683/j.wph.2023.02.004
Feijuan KONG, Jingzhu WU, Xiaoying DING. Research progresson the role of glucose-dependent insulinotropic ploypeptide/glucagon-like peptide-1 dual receptor agonists in blood glucose control[J]. World Clinical Drug, 2023 , 44 (2) : 122 -127 . DOI: 10.13683/j.wph.2023.02.004
  • 上海市自然科学基金面上项目(21ZR1451300)
  • 上海市“医苑新星”青年医学人才培养资助计划专科项目
参考文献 引证文献
排序方式:
[1]
Bayliss WM, Starling EH. The mechanism of pancreatic secretion[J]. J Physiol, 1902, 28(5): 325-353.
[2]
Moore B. On the treatment of diabetus mellitus by acid extract of duodenal mucous membrane[J]. Biochem J, 1906, 1(1): 28-38.
[3]
Mcintyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance[J]. Lancet, 1964, 2(7349): 20-21.
[4]
Unger RH, Eisentraut AM. Entero-insular axis[J]. Arch Intern Med, 1969, 123(3): 261-266.
[5]
Eissele R, Göke R, Willemer S, et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man[J]. Eur J Clin Invest, 1992, 22(4): 283-291.
[6]
Takeda J, Seino Y, Tanaka K, et al. Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor[J]. Proc Natl Acad Sci USA, 1987, 84(20): 7005-7008.
[7]
Diakogiannaki E, Gribble FM, Reimann F. Nutrient detection by incretin hormone secreting cells[J]. Physiol Behav, 2012, 106(3): 387-393.
[8]
Caruso I, Cignarelli A, Giorgino F. Heterogeneity and similarities in GLP-1 receptor agonist cardiovascular outcomes trials[J]. Trends Endocrinol Metab, 2019, 30(9): 578-589.
[9]
Ma X, Liu Z, Ilyas I, et al. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential[J]. Int J Biol Sci, 2021, 17(8): 2050-2068.
[10]
Højberg PV, Vilsbøll T, Rabøl R, et al. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes[J]. Diabetologia, 2009, 52(2): 199-207.
[11]
Frias JP, Bastyr EJ 3rd, Vignati L, et al. The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes[J]. Cell Metab, 2017, 26(2): 343-352.
[12]
Frias JP, Nauck MA, Van J, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial[J]. Lancet, 2018, 392(10160): 2180-2193.
[13]
Usdin TB, Mezey E, Button DC, et al. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain[J]. Endocrinology, 1993, 133(6): 2861-2870.
[14]
Gromada J, Bokvist K, Ding WG, et al. Glucagon-like peptide 1(7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling[J]. Diabetes, 1998, 47(1): 57-65.
[15]
Lewis JT, Dayanandan B, Habener JF, et al. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist[J]. Endocrinology, 2000, 141(10): 3710-3716.
[16]
Irwin N, Gault V, Flatt PR. Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?[J]. Expert Opin Investig Drugs, 2010, 19(9): 1039-1048.
[17]
Villar HV, Fender HR, Rayford PL, et al. Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP)[J]. Ann Surg, 1976, 184(1): 97-102.
[18]
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP[J]. Gastroenterology, 2007, 132(6): 2131-2157.
[19]
Elahi D, McAloon-Dyke M, Fukagawa NK, et al. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1(7-37) in normal and diabetic subjects[J]. Regul Pept, 1994, 51(1): 63-74.
[20]
Finan B, Ma T, Ottaway N, et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans[J]. Sci Transl Med, 2013, 5(209): 209ra151.
[21]
Gallwitz B, Witt M, Fölsch UR, et al. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide on RINm5F insulinoma cells[J]. J Mol Endocrinol, 1993, 10(3): 259-268.
[22]
Delmeire D, Flamez D, Moens K, et al. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent β cell responsiveness[J]. Biochem Pharmacol, 2004, 68(1): 33-39.
[23]
Lupi R, Del GS, D'Aleo V, et al. The direct effects of GLP-1 and GIP, alone or in combination, on human pancreatic islets[J]. Regul Pept, 2010, 165(2-3): 129-132.
[24]
Gault VA, Kerr BD, Harriott P, et al. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with type 2 diabetes and obesity[J]. Clin Sci (Lond), 2011, 121(3): 107-117.
[25]
Pathak NM, Pathak V, Gault VA, et al. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential[J]. Biochem Pharmacol, 2018, 155: 264-274.
[26]
Irwin N, Hunter K, Frizzell N, et al. Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice[J]. Regul Pept, 2009, 153(1-3): 70-76.
[27]
Killion EA, Wang J, Yie J, et al. Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models[J]. Sci Transl Med, 2018, 10(472): eaat3392.
[28]
Mentis N, Vardarli I, Köthe LD, et al. GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes[J]. Diabetes, 2011, 60(4): 1270-1276.
[29]
Krarup T, Saurbrey N, Moody AJ, et al. Effect of porcine gastric inhibitory polypeptide on β-cell function in type Ⅰand type Ⅱ diabetes mellitus[J]. Metabolism, 1987, 36(7): 677-682.
[30]
Schmitt C, Portron A, Jadidi S, et al. Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus[J]. Diabetes Obes Metab, 2017, 19(10): 1436-1445.
[31]
Portron A, Jadidi S, Sarkar N, et al. Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects[J]. Diabetes Obes Metab, 2017, 19(10): 1446-1453.
[32]
Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept[J]. Mol Metab, 2018, 18: 3-14.
[33]
Rosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial[J]. Lancet, 2021, 398(10295): 143-155.
[34]
Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes[J]. N Engl J Med, 2021, 385(6): 503-515.
[35]
Ludvik B, Giorgino F, Jódar E, et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial[J]. Lancet, 2021, 398(10300): 583-598.
[36]
Del PS, Kahn SE, Pavo I, et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial[J]. Lancet, 2021, 398(10313): 1811-1824.
[37]
Provenzano M, Pelle MC, Zaffina I, et al. Sodium-glucose co-transporter-2 inhibitors and nephroprotection in diabetic patients: more than a challenge[J]. Front Med (Lausanne), 2021, 8: 654557.
[38]
Coppolino G, Leporini C, Rivoli L, et al. Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials[J]. Pharmacol Res, 2018, 129: 274-294.
[39]
Li VM, Fuiano G, Francesco M, et al. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency[J]. Nephron Clin Pract, 2007, 105(2): c62-c67.
2023年第44卷第2期
16
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.02.004
  • 接收时间:2022-10-28
  • 首发时间:2026-11-18
  • 出版时间:2023-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-10-28
  • 修回日期:2023-01-12
基金
上海市自然科学基金面上项目(21ZR1451300)
上海市“医苑新星”青年医学人才培养资助计划专科项目
作者信息
    上海交通大学附属第一人民医院内分泌代谢科,上海 200080

通讯作者:

丁晓颖,主任医师,内分泌系统疾病的诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.02.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏